BioNxt Solutions (BioNxt Solutions) FCF Margin % : -24,333.33% (As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is BioNxt Solutions FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. BioNxt Solutions's Free Cash Flow for the three months ended in Mar. 2024 was $-0.73 Mil. BioNxt Solutions's Revenue for the three months ended in Mar. 2024 was $0.00 Mil. Therefore, BioNxt Solutions's FCF Margin % for the quarter that ended in Mar. 2024 was -24,333.33%.

As of today, BioNxt Solutions's current FCF Yield % is -5.90%.

The historical rank and industry rank for BioNxt Solutions's FCF Margin % or its related term are showing as below:

BNXTF' s FCF Margin % Range Over the Past 10 Years
Min: -7709.09 Med: -2098.99 Max: -1443.28
Current: -7709.09

During the past 6 years, the highest FCF Margin % of BioNxt Solutions was -1443.28%. The lowest was -7709.09%. And the median was -2098.99%.

BNXTF's FCF Margin % is ranked worse than
98.73% of 1023 companies
in the Drug Manufacturers industry
Industry Median: 0.29 vs BNXTF: -7709.09

BioNxt Solutions FCF Margin % Historical Data

The historical data trend for BioNxt Solutions's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioNxt Solutions FCF Margin % Chart

BioNxt Solutions Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

-1,830.38

-2,995.93

-4,416.59

-2,095.43

-1,444.77

BioNxt Solutions Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Sep23	Dec23	Mar24
FCF Margin %	Get a 7-Day Free Trial															-3,992.31	-934.68	-	-6,440.00	-24,333.33

Competitive Comparison of BioNxt Solutions's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, BioNxt Solutions's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BioNxt Solutions's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, BioNxt Solutions's FCF Margin % distribution charts can be found below:

* The bar in red indicates where BioNxt Solutions's FCF Margin % falls into.

BioNxt Solutions FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

BioNxt Solutions's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-4.002	/	0.277
	=	-1,444.77 %

BioNxt Solutions's FCF Margin for the quarter that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	-0.73	/	0.003
	=	-24,333.33 %

BioNxt Solutions FCF Margin % Related Terms

Thank you for viewing the detailed overview of BioNxt Solutions's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

BioNxt Solutions (BioNxt Solutions) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » BioNxt Solutions Inc (OTCPK:BNXTF) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

BXT:Germany BNXT:Canada

Address

1820 Fir Street, Suite 270, Vancouver, BC, CAN, V6J 3B1

Website

https://www.bionxt.com

BioNxt Solutions Inc is a cannabis company engaged in developing analytical testing, processing, and formulation capability in Canada. It is also engaged in research, cultivation, extraction, import, distribution, and manufacturing in Germany. The products of the company include Drug Delivery, Point-of-Care Diagnostics, and Psychedelics.